期刊文献+

血糖与血清C反应蛋白关系的研究 被引量:1

Relationship between blood glucose and C-reactive protein.
下载PDF
导出
摘要 目的观察2型糖尿病T2DM和糖耐量低减IGT患者血清C反应蛋白CRP的水平,探讨CRP在高血糖发生中的作用。方法所有受试者均经口服葡萄糖耐量试验OGTT,用乳胶增强速率免疫散射比浊法测定三组受试者血清CRP水平。结果正常对照NCI、GT和T2DM者血清CRP水平逐渐升高,分别为(1.31±0.47)mg/L、(2.43±0.40)mg/L和(3.95±0.88)mg/L,组间比较差异有统计学意义,以下同(P<0.01);CRP分别与体重指数BMI、腰围、收缩压、舒张压、空腹血糖FPG、OGTT2 h PG、HbA1c、胰岛素抵抗指数HOMA-IR、三酰甘油三酯TG和总胆固醇TC呈正相关。结论慢性低度炎症不仅在T2DM而且在IGT状态已经存在。 Objective To observe the levels of C - reactive protein(CRP) in patients with type 2 diabetes mellitus(T2DM)and impaired glucose tolerance(IGT), and to study the rule of CRP in the development of hyperglycemia. Methods All subjects in the study underwent a 75 g oral glucose tolerance test (OGTY). Determination of serum CRP levels in normal controls(NC), IGT and T2DM patients was made by latex - enhanced immunonephelometric assay. Results The serum levels of CRP were 1.31 ± 0.47mg/L in NC,2.43 ± 0.40 mg/L in IGT patients, and 3.95 ± 0.88 mg/L in T2DM patients. The serum levels of CRP were positively correlated with body mass index(BMI)( r = 0.275, P 〈0.05), waist circumference( r =0.354, P 〈0.01), systolic blood pressure( r = 0.247, P 〈0.05), diastolic blood pressure r =0.233, P 〈0.05), fasting plasma glucose(FPG r=0.513, P〈0.01), OGTY2 h PG( r=0.526, P 〈0.01), hemoglobin Alc HbAlc r = 0.483, P 〈 0.01), homeostasis model assessment index of insulin resistance(HOMA- IR r=0.503, P 〈 0.01), triglyceride r =0.381, P 〈0.01) ,and total cholesterol(TC) ( r = 0.282, P 〈 0.05). Conclusion Low- grade chronic inflammation exists not only in patients with T2DM but also in patients with IGT.
出处 《武警医学》 CAS 2005年第11期806-808,共3页 Medical Journal of the Chinese People's Armed Police Force
关键词 C反应蛋白 非胰岛素依赖型糖尿病 葡萄糖耐量异常 C - reactive protein Non-insulin- dependent diabetes mellitus Impaired glucose tolerance
  • 相关文献

参考文献6

  • 1Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 2004, 27(3): 813 - 823
  • 2Duncan BB, Schmidt MI, Pankow JS et al . Low- grade systemic inflammation and the development of type 2 diabetes: the arteriosclerosis risk in communities study. Diabetes, 2003, 52(7): 1799- 1805
  • 3Hun FB, Meigs JB, Li TY et al . Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes,2004,53(3): 693 - 700
  • 4Pradhan AD, Manson JE, Raffia N et al . C - reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001, 286(3):327-334
  • 5王先令,陆菊明,潘长玉.不同糖耐量水平者血清C反应蛋白水平及阿卡波糖干预的影响[J].中华内分泌代谢杂志,2003,19(4):254-256. 被引量:43
  • 6项坤三,贾伟平,陆俊茜,唐竣玲,李杰.中国上海地区40岁以上成人中肥胖与代谢综合征的关系[J].中华内科杂志,2000,39(4):224-228. 被引量:128

二级参考文献9

  • 1中华心血管病杂志编委会血脂异常防治对策专,中华心血管病杂志,1997年,25卷,169页
  • 2Temelkova-Kurktschiev T, Henkel E, Schaper F, et al. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia and underestimated evil? Exp Clin Endocrinol Diabetes, 2000,108:93-99.
  • 3Pickup JC, Crook MA. Is type Ⅱ diabetes mellitus a disease of the innate immune system? Diabetologia, 1998,41:1241-1248.
  • 4Pickup JC, Mattock MB, Chuseney GD, et al. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia, 1997,40:1286-1292.
  • 5McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism, 1989,38:1042-1046.
  • 6Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
  • 7Ebeling P, Tepppo AM, Koistinen HA, et al. Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins with type Ⅱ diabetes. Diabetologia, 1999,42:1433-1438.
  • 8Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science, 2001,293:1673-1677.
  • 9董吉祥,石永兵,韩惠琴,沈华英,谢炜,谢莹,刘志达,张学光.2型糖尿病患者血清白细胞介素-6、肿瘤坏死因子-α水平与T细胞亚群变化的研究[J].中华内分泌代谢杂志,1999,15(6):370-371. 被引量:21

共引文献169

同被引文献9

  • 1王丽芳,董小英,赵兴.糖尿病合并冠心病患者的糖化血红蛋白及C反应蛋白的测定及其临床意义[J].宁夏医学杂志,2006,28(9):683-684. 被引量:20
  • 2Sander D, Schulze-I-Iorn C, Bickel H, et al. Combined effects of hemoglobin Alc and C-reactive protein on the progression of subclinical carotid atherosclerosis : the INVADE study [ J ]. Stroke, 2006,37 (2) : 351 - 357.
  • 3Rivera JJ, Choi EK, Yoon YE, et al. Association between increasing lev- els of hemoglobin Alc and coronary atherosclerosis in asymptornatic indi- viduals without diabetes mellitus[ J]. Coron Artery Dis, 2010,21 (3) : 157 - 163.
  • 4Ross R. The pathogenesis of atherosclerosis: a perspective for the1990s [ J]. Nature, 1993,362(6423) : 801 - 809.
  • 5Anderson JL, Carlquist JF, Muhlestein JB, et al. Evaluation of C-reactive protein,an inflammatory marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction[J]. J Am Coil Cardiol, 1998,32(1):35 -41.
  • 6Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumaniae and atherosclerosis[ J]. Heart, 1999,81 (3) : 232 - 238.
  • 7Basta G, Schmidt AM, Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in dia- betes[J]. Cardiovasc Res,2004,63(4) :582 - 592.
  • 8Marfella R, Filippo C, Baldi A. The vascular smooth muscle ceils apopto- sis in asymptornatic diabetic carotid plaques: role of glycamic control[J]. J Am Coil Cardiol,2006,47(10):2118- 2120.
  • 9李军平.糖尿病血液流变学指标检测与糖化血红蛋白的相关性研究[J].苏州医学院学报,2000,20(5):460-461. 被引量:6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部